Gemini Therapeutics logo
Gemini Therapeutics GMTX
$ 1.56 0.97%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Gemini Therapeutics Total Current Liabilities 2011-2024 | GMTX

Annual Total Current Liabilities Gemini Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
21.4 M 22.6 M 13.4 M 598 K - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
22.6 M 598 K 14.5 M